GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Consort Medical PLC (GREY:CSRMY) » Definitions » EV-to-EBIT

Consort Medical (Consort Medical) EV-to-EBIT : 51.13 (As of May. 04, 2024)


View and export this data going back to . Start your Free Trial

What is Consort Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Consort Medical's Enterprise Value is $533.1 Mil. Consort Medical's EBIT for the trailing twelve months (TTM) ended in Oct. 2019 was $10.4 Mil. Therefore, Consort Medical's EV-to-EBIT for today is 51.13.

The historical rank and industry rank for Consort Medical's EV-to-EBIT or its related term are showing as below:

CSRMY's EV-to-EBIT is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 20.215
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Consort Medical's Enterprise Value for the quarter that ended in Oct. 2019 was $0.0 Mil. Consort Medical's EBIT for the trailing twelve months (TTM) ended in Oct. 2019 was $10.4 Mil. Consort Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2019 was %.


Consort Medical EV-to-EBIT Historical Data

The historical data trend for Consort Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consort Medical EV-to-EBIT Chart

Consort Medical Annual Data
Trend Apr10 Apr11 Apr12 Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 Apr19
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.53 38.07 23.52 31.80 33.49

Consort Medical Semi-Annual Data
Apr10 Oct10 Apr11 Oct11 Apr12 Oct12 Apr13 Oct13 Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 31.80 - 33.49 -

Competitive Comparison of Consort Medical's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Consort Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Consort Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Consort Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Consort Medical's EV-to-EBIT falls into.



Consort Medical EV-to-EBIT Calculation

Consort Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=533.088/10.427
=51.13

Consort Medical's current Enterprise Value is $533.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Consort Medical's EBIT for the trailing twelve months (TTM) ended in Oct. 2019 was $10.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Consort Medical  (GREY:CSRMY) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Consort Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2019 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Oct. 2019 ) =EBIT / Enterprise Value (Q: Oct. 2019 )
=10.427/0
= %

Consort Medical's Enterprise Value for the quarter that ended in Oct. 2019 was $0.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Consort Medical's EBIT for the trailing twelve months (TTM) ended in Oct. 2019 was $10.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Consort Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Consort Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Consort Medical (Consort Medical) Business Description

Traded in Other Exchanges
N/A
Address
Breakspear Way, Suite B Breakspear Park, Hemel Hempstead, Hertfordshire, GBR, HP2 4TZ
Consort Medical PLC is part of the healthcare sector in the United Kingdom. It is one of the leading contract manufacturers in the field of drug delivery devices. Its core products include an inhaler, auto-injector, nasal and ocular technologies which it supplies to pharmaceutical companies. Along with devices, the company also specializes in drugs including active pharmaceutical ingredients and finished dose formulations.

Consort Medical (Consort Medical) Headlines

No Headlines